- Type / Class
- Equity / CL A
- Total 13F shares
- 7,706,363
- Share change
- 0
- Total reported value
- $37,607,051
- Price per share
- $4.88
- Number of holders
- 1
Quarterly Holders Quick Answers
What is CUSIP 75629V104?
CUSIP 75629V104 identifies 75629V104 - RECURSION PHARMACEUTICALS IN - CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75629V104:
Top shareholders of 75629V104 - RECURSION PHARMACEUTICALS IN - CL A (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of RECURSION PHARMACEUTICALS IN - CL A as of Q3 2025
As of 30 Sep 2025,
RECURSION PHARMACEUTICALS IN - CL A was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
7,706,363 shares.
The largest 2 holders included
NVIDIA CORP and CITADEL ADVISORS LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q3 2024 Across Filers
Q3 2024 holders
1
Q3 2025 holders
1
Holder diff
0
| Investor | Q3 2024 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.